The document summarizes India's Revised National Tuberculosis Control Programme (RNTCP). It discusses that over 6000 people develop TB and 600 die from it daily in India. The objectives of RNTCP are to achieve 85% cure rate of infectious cases and detect 70% of estimated cases. It operates using the WHO recommended DOTS strategy involving diagnosis, standardized treatment, drug supply management, and monitoring/evaluation. New initiatives include expanding use of CBNAAT and establishing an online case reporting system. The program aims to achieve universal access to TB diagnosis and treatment.
This ppt contains all the information about Revised NationalTuberculosis Control programme (RNTCP) It is useful for students of the medical field learning Preventive and social medicine, Swasthavritta (Ayurved) and everyone who is interested in in knowing about it.
This is IPHS presentation .hope it is helpful to you. contents are - introduction,origin of iphs, iphs for subcenter,phc, in maharashtra ,summary and references
National leprosy eradication program CHNNehaNupur8
Leprosy is a chronic infectious disease caused by ‘Mycobacterium Leprae’ an acid fast , rod shaped bacillus.
The disease mainly affects the skin , the peripheral nerves , mucosa of the upper respiratory tract and also eyes.
Cardinal Features:-
° Hypopigmented patch
° Loss of cutaneous sensation
° Thickened Nerve
° Acid fast bacilli
Leprosy has been regarded by tbe community as a contagious , mutilating and incurable disease.
Leprosy is curable and treatment provided in the early stages averts disability.
Multidrug Therapy (MDT) treatment has been made available by WHO free of charge to all patients worldwide since 1995, and provides a simple yet highly effective cure for all typesof leprosy.
This ppt gives you the details about the NRHM scheme. The SWOT analysis has been done which helps you to know the strength and weakness part of the NRHM program.
BY: Dr.Pavithra R (M.H.A)
This ppt contains all the information about Revised NationalTuberculosis Control programme (RNTCP) It is useful for students of the medical field learning Preventive and social medicine, Swasthavritta (Ayurved) and everyone who is interested in in knowing about it.
This is IPHS presentation .hope it is helpful to you. contents are - introduction,origin of iphs, iphs for subcenter,phc, in maharashtra ,summary and references
National leprosy eradication program CHNNehaNupur8
Leprosy is a chronic infectious disease caused by ‘Mycobacterium Leprae’ an acid fast , rod shaped bacillus.
The disease mainly affects the skin , the peripheral nerves , mucosa of the upper respiratory tract and also eyes.
Cardinal Features:-
° Hypopigmented patch
° Loss of cutaneous sensation
° Thickened Nerve
° Acid fast bacilli
Leprosy has been regarded by tbe community as a contagious , mutilating and incurable disease.
Leprosy is curable and treatment provided in the early stages averts disability.
Multidrug Therapy (MDT) treatment has been made available by WHO free of charge to all patients worldwide since 1995, and provides a simple yet highly effective cure for all typesof leprosy.
This ppt gives you the details about the NRHM scheme. The SWOT analysis has been done which helps you to know the strength and weakness part of the NRHM program.
BY: Dr.Pavithra R (M.H.A)
After the successful NSP 2017-2025,Goi is lauching NSP 2017-2025 for elimination of TB on 24th march( World TB day ) 2017. Module is on MOHFW site but i have try to keep it brief,hope its ll be useful specially for academic and administrative purposes.
Universal health coverage (UHC) is a vision where all people and communities have access to quality health services where and when they need them, without suffering financial hardship. It includes the full spectrum of services needed throughout life—from health promotion to prevention, treatment, rehabilitation, and palliative care—and is best based on a strong primary health care system.
The Union Health and Family Welfare Minister J P Nadda on 15 May 2015 launched kayakalp Award Scheme.
The scheme is intended to encourage and incentivize Public Health Facilities (PHFs) in the country to demonstrate high levels of cleanliness, hygiene and infection control practices.
The objectives of the award scheme is to promote cleanliness, hygiene and infection control practices in public health care facilities, to incentivize and recognize such public healthcare facilities that show exemplary performance in adhering to standard protocols of cleanliness and infection control, to inculcate a culture of ongoing assessment and peer review of performance related to hygiene, cleanliness and sanitation, to create and share sustainable practices related to improved cleanliness in public health facilities linked to positive health outcomes.
To understand:
The principles of detecting and controlling an
outbreak.
What is needed for outbreak investigation
Steps in disease outbreak investigations.
Women's empowerment has become a significant topic of discussion in development and economics. It can also point to approaches regarding other trivialized genders in a particular political or social context. Women's economic empowerment refers to the ability for women to enjoy their rights to control and benefit from resources, assets, income and their own time, as well as the ability to manage risk and improve their economic status and well being. While often interchangeably used, the more comprehensive concept of gender empowerment refers to people of any gender, stressing the distinction between biological sex and gender as a role. It thereby also refers to other marginalized genders in a particular political or social context.
It is not necessary (although desirable) to know everything about the natural history of a disease to initiate preventive measures. Often times, removal or elimination of a single known essential cause may be sufficient to prevent a disease. The objective of preventive medicine is to intercept or oppose the "cause" and thereby the disease process. The epidemiological concept permits the inclusion of treatment as one of the modes of intervention.
RTS,S/AS01 (RTS,S) is a malaria vaccine that has been developed through a partnership between GlaxoSmithKline Biologicals (GSK) and the PATH Malaria Vaccine Initiative (MVI), with support from the Bill & Melinda Gates Foundation and from a network of African research centers that performed the studies.
Influenza vaccines or flu shots protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Their effectiveness varies from year to year, most provide modest to high protection against influenza.
Integrated Disease Surveillance Project (IDSP) was launched by Hon’ble Union Minister of Health & Family Welfare in November 2004 for a period upto March 2010. The project was restructured and extended up to March 2012. The project continues in the 12th Plan with domestic budget as Integrated Disease Surveillance Programme under NHM for all States with Budgetary allocation of 640 Cr.
A Central Surveillance Unit (CSU) at Delhi, State Surveillance Units (SSU) at all State/UT head quarters and District Surveillance Units (DSU) at all Districts in the country have been established.
Objectives:
To strengthen/maintain decentralized laboratory based IT enabled disease surveillance system for epidemic prone diseases to monitor disease trends and to detect and respond to outbreaks in early rising phase through trained Rapid Response Team (RRTs)
Programme Components:
Integration and decentralization of surveillance activities through establishment of surveillance units at Centre, State and District level.
Human Resource Development – Training of State Surveillance Officers, District Surveillance Officers, Rapid Response Team and other Medical and Paramedical staff on principles of disease surveillance.
Use of Information Communication Technology for collection, collation, compilation, analysis and dissemination of data.
Strengthening of public health laboratories.
Social Security scheme for Women and Old age PeopleVivek Varat
Social security may also refer to the action programs of government intended to promote the welfare of the population through assistance measures guaranteeing access to The loss of support suffered by a widow or child as the result of the death of the breadwinner (survivor’s benefit);
Responsibility for the maintenance of children (family benefit);
The treatment of any morbid condition (including pregnancy), whatever its cause (medical care);
A suspension of earnings due to pregnancy and confinement and their consequences (maternity benefit);
A suspension of earnings due to an inability to obtain suitable employment for protected persons who are capable of, and available for, work (unemployment benefits);
A suspension of earnings due to an incapacity for work resulting from a morbid condition (sickness leave benefit);
A permanent or persistent inability to engage in any gainful activity (disability benefits);
The costs and losses involved in medical care, sickness leave, invalidity and death of the breadwinner due to an occupational accident or disease (employment injuries).
People who cannot reach a guaranteed social minimum for other reasons may be eligible for social assistance (or welfare, in American English).
Modern authors often consider the ILO approach too narrow. In their view, social security is not limited to the provision of cash transfers, but also aims at security of work, health, and social participation; and new social risks (single parenthood, the reconciliation of work and family life) should be included in the list as well.
National Vector Borne Disease Control Programme (NVBDCP)Vivek Varat
The National Vector Borne Disease Control Programme (NVBDCP) is an umbrella programme for prevention and control of malaria and other vector borne diseases. Under the programme, it is ensured that the disadvantaged and marginalised sections benefit from the delivery of services so that the desired National Health Policy and Rural Health Mission goals are achieved. The Directorate of NVBDCP under the Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, is the nodal agency responsible for planning, coordination, implementation, monitoring and evaluation of NVBDCP programme at all levels.
National Program for Prevention and Control of Cancer, Diabetes, CVD and Stro...Vivek Varat
Government of India initiated a National Programme for Prevention and Control of Cancers, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) during 2010-11 after integrating the National Cancer Control Programme (NCCP) with (NPDCS).
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
4. Burden of TB
In India everyday
More than 6000 people develop TB diseases
More than 600 people die of TB ( i.e. 2 deaths in every 5 mins )
5. NATIONAL TUBERCULOSIS PROGRAM
(NTP)
Operational since 1962.
Unacceptably low success rate.
Spread of multidrug resistant TB.
Managerial weakness
Inadequate funding.
Over-reliance of X-ray for diagnosis.
Frequent interrupted supplies of drugs.
Low rate of treatment completion.
6. Evolution of TB Control in India
1950s-60s Important TB research at TRC and NTI
1962 National TB Programme (NTP)
1992 Programme Review
◦ only 30% of patients diagnosed;
◦ of these, only 30% treated successfully
1993 RNTCP pilot began
1998 RNTCP scale-up
2001 450 million population covered
2004 >80% of country covered
2006 Entire country covered by RNTCP
7. Revised national tuberculosis control
programme (RNTCP)
Launched in 1997 based on WHO DOTS Strategy
◦ Entire country covered in March’06 through an unprecedented rapid expansion of DOTS
Implemented as 100% centrally sponsored program
◦ Govt. of India is committed to continue the support till TB ceases to be a public health
problem in the country
All components of the STOP TB Strategy-2006 are being
implemented
9. Objectives
Achievement of at least 85% cure rate of infectious cases; through
DOTS involving peripheral health functionaries.
Augmentation of case finding activities through quality sputum
microscopy to detect at least 70% of estimated cases.
10. Directly Observed Treatment, Short Course, comprises five components
1. Sustained political and financial commitment. TB can be cured & the epidemic
reversed if adequate resources and administrative support for control are provided
2. Diagnosis by quality ensured sputum-smear microscopy.
3. Standardized short-course anti-TB treatment (SCC) given under direct and
supportive observation (DOT).Helps to ensure the right drugs are taken at the right
time for the full duration of treatment.
4. A regular, uninterrupted supply of high quality anti-TB drugs. Ensures that a
credible national TB programme does not have to turn anyone away.
5. Standardized recording and reporting. Helps to keep track of each individual
patient and to monitor overall programme performance
12. 1. Pursue high-quality DOTS expansion
and enhancement.
a. Secure political commitment, with adequate and sustained financing.
b. Ensure early case detection, and diagnosis through quality-assured bacteriology.
c. Provide standardized treatment with supervision, and patient support.
d. Ensure effective drug supply and management.
e. Monitor and evaluate performance and impact.
13. 2. Address TB-HIV, MDR-TB, and the needs of
poor and vulnerable populations
a. Scale-up collaborative TB/HIV activities.
b. Scale-up prevention and management of multidrug-resistant TB (MDR-TB).
c. Address the needs of TB contacts, and of poor and vulnerable populations.
14. 3. Contribute to health system strengthening
based on primary health care
a. Help improve health policies, human resource development, financing, supplies,
service delivery and information.
b. Strengthen infection control in health services, other congregate settings and
households.
c. Upgrade laboratory networks, and implement the Practical Approach to Lung Health
(PAL).
d. Adapt successful approaches from other fields and sectors, and foster action on the
social determinants of health.
15. 4. Engage all care providers
a. Involve all public, voluntary, corporate and private providers through Public-Private
Mix (PPM) approaches.
b. Promote use of the International Standards for Tuberculosis Care (ISTC).
16. 5. Empower people with TB, and
communities through partnership.
a. Pursue advocacy, communication and social mobilization.
b. Foster community participation in TB care, prevention and health promotion.
c. Promote use of the Patients' Charter for Tuberculosis Care.
17. 6. Enable and promote research
a. Conduct programme-based operational research.
b. Advocate for and participate in research to develop new diagnostics, drugs and
vaccines.
20. Introduction
RNTCP has quality assured laboratory network for bacteriological examination of
sputum in a three tier system consisting of
◦ Designated Microscopy Centre (DMC),
◦ Intermediate Reference laboratory (IRL),
◦ National Reference laboratory (NRL).
One of its National Reference laboratories (National Institute for Research in
Tuberculosis – formerly TRC), Chennai is also one of the WHO designated supra-
national reference laboratory (SNRL) for the South East Asia Region since 1997
and another the National Institute of TB and Respiratory Diseases (NITRD) New
Delhi has been designated as a centre of excellence for TB mycobacteriology by
WHO in the recent past.
22. National Reference Laboratory (NRL)
NRL conducts annual On-site evaluation/supervisory visits to
laboratories for assessing quality of microscopy, Culture and DST, and
for improvement of overall laboratory quality .
The programme has provided HR support by way of three
microbiologists and four senior laboratory technicians to each NRL
for these activities under the head of NRL strengthening.
The functions of the NRLs include conduct of Culture and DST
trainings to the IRLs, develop SOPs for the technical procedures,
equipment maintenance, infection control, and recording and
reporting.
23. Intermediate Reference Laboratory (IRL)
There is at least one IRL per state.
Its functions is to provide culture and DST for the category IV
services in the State .
The IRL conducts on-site evaluation visits to districts for sputum
microscopy at least once a year.
The IRL undertakes panel testing of STLS at each DTC.
The IRL ensures the proficiency of staff performing RNTCP smear
microscopy activities by providing training to laboratory technicians
and STLS.
24. Designated Microscopy Centre (DMC)
The most peripheral laboratory under the RNTCP network is the
designated microscopy centre (DMC) which serves a population of
around 100,000 (50,000 in tribal and hilly areas).
RNTCP has provided financial assistance for upgrading existing
health facilities, supplied a binocular microscope for each DMC and
ensured adequate supply of staining reagent and consumables at the
DMCs.
DMCs are manned by a trained laboratory technician (LT) of the
state health system.
25. RNTCP External Quality Assessment
o Panel testing
o On‐site evaluation
o Random blinded rechecking of routine slides
27. 1. Smear Microscopy (for AFB)
– Sputum smear stained with
Zeil-Nelson Staining or
– Fluorescence stains and
examined under direct or
indirect microscopy with or
without LED.
28. 2. Culture
– Solid (Lowenstein Jansen) media or Liquid media (Middle Brook)
using manual, semiautomatic or automatic machines e.g. Bactec ,
MGIT etc.
29. 3. Rapid diagnostic molecular test
– Conventional PCR based Line
Probe Assay for MTB complex or
Real-time PCR based Nucleic
Acid Amplification Test (NAAT)
for MTB complex e.g. GeneXpert
Note: Diagnosis of TB basedon radiology (e.g.
X-ray) will be termed as clinical TB.
31. Multi Drug Resistance Tuberculosis
(MDR-TB)/ Rifampicin Resistance
Patient with a drug susceptibility test result from a RNTCP-certified
laboratory or WRD (WHO-endorsed Rapid Diagnostics) drug
susceptibility test report showing resistance to rifampicin.
o Rapid Molecular Test ( LPA/ CB-NAAT)
o Liquid Culture & DST
o Solid Culture & DST
32. XDR TB case
An MDR TB case whose recovered M. tuberculosis isolate is resistant
to at least isoniazid, rifampicin, a fluoroquinolone (ofloxacin,
levofloxacin, or moxifloxacin) and a second-line injectable antiTB
drug (kanamycin, amikacin, or capreomycin) at a RNTCP-certified
Culture & DST Laboratory.
o Liquid Culture & DST
o Solid Culture & DST
34. 1.CBNAAT (Cartridge Based Nucleic Acid
Amplification Test)
CBNAAT is an automated Cartridge Based
Nucleic Acid Amplification Test that has
demonstrated its potential to detect
tuberculosis and Rifampicin resistance with high
accuracy.
It is also called Gene Xpert MTB/RIF (Cepheid
Inc, USA) test, a highly sensitive and specific tool
with a quick turn-around time (TAT), offer early
diagnosis of TB and DR-TB) in the programmatic
settings amongst adult and children as well.
Currently 80 such CBNAAT machines deployed
across the country
35. 2.Case-based web-based reporting
system (NIKSHAY)
The database of RNTCP was conventionally on Epiinfo based software for
reporting with electronic data transmission from district level upwards.
CTD in collaboration with National Informatics Centre (NIC) developed a case
based web-based online (Cloud) application - ‘Nikshay’, launched in May 2012,
which has been now scaled up nationally.
36. NIKSHAY
It has following components –
• Master management
• User details
• TB patient registration & detail of diagnosis, DOT
provider, HIV status, follow up, contact tracing,
outcome
• Details of Solid and liquid culture & Drug Sensitivity
Testing (DST), Luciferin Probe Assay (LPA), CBNAAT
• DRTB patient registration with details
• Referral & transfer of patients
• Private health facility registration and notification
• Mobile application for TB notification
• SMS alert to patients on registration and to
programme
officer
• Automated periodic report (case finding, sputum
conversion and outcome).
37. 3.TB notification
In order to ensure proper TB diagnosis and case management, reduce TB
transmission and address the problems of emergence and spread of DRTB, it is
essential to have complete information of all TB cases.
To curb this situation, Government of India declared Tuberculosis a notifiable
disease on 7th May 2012 mandating all the healthcare providers to notify every
TB case diagnosed and/or treated to local authorities .
A total of >57,000 private health facilities are registered till now.
Till now >41,000 TB cases have been notified by private sector in addition to
~5,000 cases notified by public sector being treated outside .
38. 4.Ban on commercial serology tests for
TB diagnosis
Ministry of Health and Family Welfare had prohibiting the import of the commercial sero-
diagnostic test kits for tuberculosis and the manufacture, sale, distribution and use of the
serodiagnostic test kits for tuberculosis on 7th June,2012.
The serological tests are based on antibody response, which is highly variable in TB and may
reflect remote infection rather than active disease.
The WHO experts Group and Strategic and Technical Advisory Group for Tuberculosis (STAG-TB)
which reviewed the data and concluded that currently available commercial serological tests
provide inconsistent and imprecise results and put patients lives in danger, therefore WHO
strongly recommended that these tests should not be used for the diagnosis of pulmonary and
extra-pulmonary TB.
This historic ban has had a big impact in reducing the use of inaccurate serological tests in India.
39.
40. Programmatic management of drug
resistant TB (PMDT) services
The term “Programmatic Management of Drug Resistant TB” (PMDT) (erstwhile DOTS Plus),
refers to programme based MDR TB diagnosis, management and treatment.
RNTCP introduced the PMDT services since 2007 to address the MDR TB issue in the country.
MDR-TB suspect criteria as per current programme guidelines.
Criteria A: All failures of new TB cases, Smear +ve previously treated cases who remain
smear +ve at 4th month onwards, All pulmonary TB cases who are contacts with known
MDR TB case
Criteria B – in addition to Criteria A, All smear +ve previously treated pulmonary TB
cases at diagnosis, Any smear +ve follow up result in new or previously treated cases
Criteria C – in addition to Criteria B, All smear −ve previously treated pulmonary TB
cases at diagnosis HIV TB co-infected cases at diagnosis
41. Policy changes related to the DOTS plus
•The definition of the MDR suspects has been revised to include ‘contacts of MDR cases who are
found to be smear positive; besides Category I failures and Category II patients who are smear
positive at 4 months or later.
•The existing exclusion criteria for MDR suspects i.e. Age < 15 years and history of intake of
second line drugs for more than 1 month in the past has been withdrawn. A new weight band
(16-25 Kgs) has been added for the treatment of the paediatric MDR patients.
•In order to make Category IV regimen more effective it has been decided to replace Ofloxacin
with Levofloxacin.
•Guidelines for the management of MDR patients with pregnancy have been finalized.
•Guidelines for the management of Extensively Drug Resistant TB (XDR TB) patients with Category
V regimen have been formulated.
42. TWELFTH FIVE YEAR PLAN – KEY ACTIVITIES
PROPOSED (2012-2017)
Ensuring early and improved diagnosis of all TB patients, through improving outreach,
vigorously expanding case-finding efforts among vulnerable populations, deploying better
diagnostics, and by extending services to patients diagnosed and treated in the private
sector.
Improving patient-friendly access to high-quality treatment for all diagnosed cases of TB,
including scaling up treatment for MDR TB nationwide.
Re-engineering programme systems for optimal alignment with National Rural Health
Mission (NRHM) at block level and human resource development for all health staff.
Enhancing supervision, monitoring, surveillance, and programme operations for
continuous quality improvement and accountability for each TB case, with programme
based research for development and incorporation of innovations into effective
programme practice.
43. Strategic vision to move towards
universal access.
Objectives of programme proposed are
To achieve 90%notification rate for all cases.
90% success rate for all new and 85% for retreated cases.
Improve the successful outcomes of treatment of MDR cases.
Decrease mortality and morbidity of HIV associated TB.
Improve out come of TB care in private sector.
Notification of TB cases
According to govt of India it is mandatory for all healthcare providers to notify every TB case to
local authorities.
44. Achievements of rntcp
Covers whole country since march 2006.
Phase II has been launched from 1st October 2006.
Increased treatment success rate from 25% in 1988 to 88% in 2010.
Reduced death rate from 29% to 4%.
More than 15million patients have been treated saving almost 2.5million lives.
Four urban DOTS project have also been launched.
45. Financial resources
India receives assistance from:
1.World Bank, in first phase.
2.DFID & World Bank in second phase.
3.DANIDA , GDF & USAID